Back
Pieris Pharmaceuticals Stock Price Chart
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pm
Sell
34
PIRS
Pieris Pharmaceuticals
Last Price:
16.52
Seasonality Move:
-19%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- The current trend is moderately bearish and PIRS is experiencing selling pressure, which indicates risk of future bearish movement.
Pieris Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.23 | Sell |
| 20-day SMA: | 17.52 | Sell |
| 50-day SMA: | 14.51 | Buy |
| 200-day SMA: | 13.2 | Buy |
| 8-day EMA: | 17.2 | Sell |
| 20-day EMA: | 17.06 | Sell |
| 50-day EMA: | 15.36 | Buy |
| 200-day EMA: | 18.01 | Sell |
Pieris Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.53 | Buy |
| Relative Strength Index (14 RSI): | 50.09 | Buy |
| Chaikin Money Flow: | -33215 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.41 - 18.05) | Sell |
| Bollinger Bands (100): | (8.76 - 16.18) | Buy |
Pieris Pharmaceuticals Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Pieris Pharmaceuticals Stock
Is Pieris Pharmaceuticals Stock a Buy?
- Pieris Pharmaceuticals share price is 16.67 while PIRS 8-day simple moving average is 17.23, which is a Sell signal.
- The stock price of PIRS is 16.67 while Pieris Pharmaceuticals 20-day SMA is 17.52, which makes it a Sell.
- Pieris Pharmaceuticals 50-day simple moving average is 14.51 while PIRS share price is 16.67, making it a Buy technically.
- PIRS stock price is 16.67 and Pieris Pharmaceuticals 200-day simple moving average is 13.20, creating a Buy signal.
PIRS Technical Analysis vs Fundamental Analysis
Sell
34
Pieris Pharmaceuticals (PIRS)
is a Sell
Is Pieris Pharmaceuticals a Buy or a Sell?
-
Pieris Pharmaceuticals stock is rated a Sell
The current Pieris Pharmaceuticals [PIRS] share price is $16.67. The Score for PIRS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Pieris Pharmaceuticals Stock Info
Market Cap:
22.01M
Price in USD:
16.67
Share Volume:
34.04K
Pieris Pharmaceuticals 52-Week Range
52-Week High:
27.20
52-Week Low:
6.20
Sell
34
Pieris Pharmaceuticals (PIRS)
is a Sell
Pieris Pharmaceuticals Share Price Forecast
-
What is the Pieris Pharmaceuticals stock price today?
The Pieris Pharmaceuticals stock price is 16.67 USD today. -
Will PIRS stock go up or go down?
Pieris Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Pieris Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Pieris Pharmaceuticals is overvalued.
Is Pieris Pharmaceuticals Stock a Buy?
- Pieris Pharmaceuticals share price is 16.67 while PIRS 8-day exponential moving average is 17.20, which is a Sell signal.
- The stock price of PIRS is 16.67 while Pieris Pharmaceuticals 20-day EMA is 17.06, which makes it a Sell.
- Pieris Pharmaceuticals 50-day exponential moving average is 15.36 while PIRS share price is 16.67, making it a Buy technically.
- PIRS stock price is 16.67 and Pieris Pharmaceuticals 200-day simple moving average is 18.01, creating a Sell signal.
Fundamental Analysis of Pieris Pharmaceuticals
Is Pieris Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $8.75 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and a decrease next year of $0.09 per share.
Technical Analysis of Pieris Pharmaceuticals
Should I short Pieris Pharmaceuticals stock?
- PIRS Moving Average Covergence Divergence (MACD) indicator is 0.53, suggesting Pieris Pharmaceuticals is a Buy
- Pieris Pharmaceuticals Relative Strength Index (RSI) is 50.09, which suggest Pieris Pharmaceuticals is overbought
- The Bollinger Bands (25) for Pieris Pharmaceuticals is (16.41 - 18.05), which suggest Pieris Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Pieris Pharmaceuticals is (8.76 - 16.18), which suggest Pieris Pharmaceuticals is a Buy
* Pieris Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.